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ABSTRACT
A model of secondary structure is proposed for the
3'-terminal sequence of the satellite tobacco mosaic
virus (STMV) RNA on the basis of phylogenetic
comparisons with tobacco mosaic virus (TMV) genomic
RNA. Sequence homologies and compensatory base
changes found between the two related viral RNAs
imply that the 3'-end of STMV RNA folds into a tRNA-
like domain similar to that found in the TMV RNA.
Accordingly, functional assays showed that STMV RNA
can be aminoacylated in vitro with histidine by yeast
histidyl-tRNA synthetase to plateaus reaching 30%.
Histidylation properties of STMV RNA were compared
to those of TMV RNA and of a canonical yeast tRNAHIs
transcript which both are chargeable to nearly 100%
plateau levels. Kinetic data indicate an excellent
catalytic efficiency of STMV RNA charging expressed
as Vma*yKm ratio, quasi-equivalent to that of TMV RNA,
and only 17-fold reduced as compared to that of the
yeast tRNAHIS transcript. Biological implications of the
structural mimicry between the tRNA-like regions of
TMV and STMV RNAs are discussed in the light of the
relationships of a satellite virus with its helper virus.
This is the first report on a chargeable tRNA-like
structure at the 3'-end of a satellite virus RNA.
INTRODUCTION
Satellite tobacco mosaic virus (STMV) (1-4) is a T= 1
icosahedral virus whose 60 identical capsid proteins of Mr
17,500 encapsidate a single stranded genome having 1059 bases
ofknown sequence (5). STMV can replicate in its host, generally
tobacco, only when the plant is co-infected with the helper tobacco
mosaic virus (TMV), a rod shaped virus upon which it is
dependent (4, 6). The STMV RNA does not show appreciable
sequence homology with TMV RNA, in terms of either genome
or coat protein amino acid sequences, except for the 3'-terminal
250 last nucleotides that exhibit 65% homology with the
corresponding sequence ofTMV RNA (5). The RNA of STMV
codes only for its coat protein plus one other small protein of
Mr 6,700 whose function, if any, is unknown (2, 4, 5).
The three-dimensional structure ofSTMV has been determined
by X-ray diffraction analysis to high resolution (7, 8). An unique
feature of this analysis was that segments of double helical RNA,
each at least seven base-pairs in length, and arising from
secondary structural elements in the RNA, could be observed
associated on the interior with each pair of coat protein subunits
making up the capsid. Altogether, nearly 45% of the entire RNA
could be accounted for by these helical segments. One could
conclude from this that the RNA inside the capsid must assume
both secondary and tertiary structures consistent with the
icosahedral distribution of the helical RNA segments on the
interior of the virus. Because so much of the viral RNA structure
was visible in this X-ray study, it became all the more important
to learn as much as possible about the structure of the remaining
nucleic acid, especially since its 3'- and 5'-extremities are likely
to be involved in the replication of the viral RNA.
It has been shown for a number of genomic RNAs of plant
viruses that their 3'-termini are folded in a tRNA-like structure
which is aminoacylatable by host or heterologous aminoacyl-
tRNA synthetases (reviewed in 9-11). They include RNAs from
tymoviruses accepting valine, RNAs from bromo-, cucumo-, and
hordeiviruses which are tyrosylatable, and RNAs from
tobamoviruses, of which TMV is a member, which are
histidylatable. It is also known that the 3'-termini of such
aminoacylatable viral RNAs have peculiar three-dimensional
foldings (e.g. 12-15), but which incorporate the essential identity
features of canonical tRNAs for discrimination and charging by
the relevant synthetases (16, 17). Beside functional arguments,
these conclusions are based on structural studies performed on
the tRNA-like domains using enzymatic and chemical probing
combined with modeling techniques. The 3'-terminus of TMV
RNA has tRNA-like properties, first illustrated by its histidylation
ability (18). Given the partial sequence homologies between
STMV and TMV RNAs, we examined the STMV RNA sequence
for a putative tRNA-like secondary folding at its 3'-terminus.
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We propose here the secondary structure for the 3'-end of
STMV RNA which presents tRNA-like features. This folding
is derived from the knowledge of the tRNA-like folding of
tobamovirus RNAs [(19, 20) and Felden et al., in preparation]
and of phylogenic comparisons of these RNAs with STMV RNA.
The presence of the major histidine identity determinant (21, 22)
within the proposed STMV tRNA-like folding suggests that this
RNA could be aminoacylated with histidine, as its TMV helper
virus. This prediction has been verified and consequently validates
the reality of the tRNA-like folding at the very 3'-end of the
STMV RNA.
MATERIALS AND METHODS
Enzymes and chemicals
Yeast histidyl-tRNA synthetase (HisRS) was an enzyme
preparation enriched by chromatographies on DEAE-cellulose,
hydroxyapatite, and phosphocellulose (23). Bacteriophage T7
RNA polymerase was isolated according to (24). Restriction
enzyme EcoT22I was purchased from United States Biochemical
Corporation (Cleveland, OH, USA). L-[3H] histidine (58
Ci/mmol) was from Amersham (Les Ulis, France). Nucleotides
were from Boehringer-Mannheim (Meylan, France). Rotiphorese
Gel 40 solutions of acrylamide and N, N'-methylene-bis-
acrylamide were from Carl Roth GmbH (Karlsruhe, Germany).
Preparation of STMV and TMV viral RNAs
STMV was purified from Nicotiana tabacum leaves co-infected
with both TMV U5 strain and STMV essentially as described
in (3). TMV virus (Strasbourg strain S) was a kind gift of J.Witz
(Strasbourg) and was prepared as described in (25). Both viral
RNAs were extracted from their capsids by two phenol
extractions and recovered by ethanol precipitation.
Spectrophotometric measurements were made to determine viral
RNA concentrations, assuming that 1 absorbance unit at 260 nm
corresponds to 40 jig.mli-I RNA in a 1 cm path-length cell. One
mole ofSTMV RNA and ofTMV RNA correspond respectively
to 0.3 106 and 2.1 106 daltons.
Preparation of tRNAHs transcript
The plasmid containing the gene of yeast tRNAHiS was
constructed as described (26) and linearized by EcoT22I
restriction nuclease before in vitro transcription. The transcription
mixture contained 40 mM Tris-HCI (pH 8.0), 22 mM MgCl2,
1 mM spermidine, 5 mM dithioerythritol, 0.01% Triton X100,
4 mM each ofATP, CTP, GTP, UTP, 15 jig of linearized DNA
for 50 tl transcription mixture, and 495 units of T7 RNA
polymerase. After an incubation step of three hours at 37°C, the
reaction was stopped by phenol / ether extraction followed by
ethanol precipitation. The transcript was separated from non-
incorporated nucleotides and DNA fragments by 12%
polyacrylamide gel electrophoresis followed by electroelution.
This made it possible to separate transcripts ending with the
correct 3 '-sequence from those presenting one or two additional
nucleotides due to T7 RNA polymerase errors during the
transcription. Purified transcripts were recovered by ethanol
precipitation. Spectrophotometric measurements were made to
determine tRNAHiS concentration as described previously.
Aminoacylation assays
Aminoacylation reactions were performed with full length viral
(27)]. Control aminoacylation was done using a tRNAHiS
transcript, deprived of modified bases, as are the two viral RNAs.
Assays were performed at 30°C ina medium containing 25 mM
Tris-HCl (pH 7.8), 15 mM MgCl2, 7.5 mM ATP, 50 ,uM
L-[3H] histidine (58 Ci/mmol) with the required concentrations
of RNA and yeast histidyl-tRNA synthetase. Aliquots were
spotted onto 3MM Whatman papers at different times and
trichloroacetic acid precipitated. Kinetic parameters (Km and
V,,,a,) were determined from Lineweaver-Burk plots. They
represent an average of three independent experiments.
RESULTS AND DISCUSSION
Secondary structure prediction for the 3'-end of the STMV
RNA
The secondary structure proposed for the 3'-non coding region
of STMV RNA (188 nt) is displayed in Figure 1. It was
constructed by mimicking the fold of the homologous region of
TMV RNA (20) and by taking into account phylogenetic
relationships between RNAs from the tobamoviridae family. In
TMV RNA, this region encompasses a tRNA-like fold (19).
Within the 188 nt of the STMV tRNA-like fold, 114 (61 %) are
identical with those ofTMV RNA and 48 nt (25 %) correspond
to 24 compensatory base-pair changes (circled in Fig. 1)
distributed in 6 out of the 7 domains of the molecule (only domain
E is strictly conserved in sequence and folding in the two RNAs).
The remaining 26 nt (14%) correspond to insertions and base
changes. Furthermore, two nucleotides are deleted. Interestingly,
insertions and deletions concern only single-stranded domains
and compensatory changes maintain the double-stranded regions
consisting in helices and pseudoknots.
The strict sequence conservation in the 899-949 region of
STMV RNA and the 6259-6300 region ofTMV Ul RNA (5,
27) (domain E in Figure 1) explains that the stretch of
pseudoknots within STMV RNA, as in TMV RNA (20), was
easily deteced [(28 and this work]. In this region of STMV RNA,
no deletion and only a few sequence insertions occur, so that
finding of compensatory base changes around conserved core E
was facilitated. As already shown for TMV RNA one decade
ago (19), a possible tRNA-like folding at the very 3'-end of
STMV RNA has also been suggested, although no explicit
proposals for a secondary structure were given (10, 29). In fact
sequence comparison of the two viral RNAs was not
straigthforward, because the presence of deletions and insertions
rendered finding of compensatory base changes difficult.
Moreover, attempts to define the actual secondary structure of
the 3'-terminus of STMV RNA failed because the algorithms
used could not predict pseudoknots (7).
Structural arguments supporting the folding of the 3'-end of
STMV RNA
Based on the secondary structure established in 1984 by Rietveld
et al. (19) and on the recent computer modeling of the TMV
tRNA-like domain (Felden et al., in preparation) it became
possible to understand conformational features of STMV RNA.
This is in particular the case for the three-way junction between
domains A, B and D that imposes the orientations of the three
super domains A, B-C, and D-E-F-G, as well as for the tRNA-
like mimicry. Three nucleotides (G59, C92, and C93) are inserted
in this three-way junction. They may decrease the structural
constraints within the STMV tRNA-like fold and likely lead to
RNAs [1059 nt for STMV RNA (5) and 6395 nt for TMV RNA an increased flexibility of this fold. Pseudoknot D (formed by
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Figure 1. Proposition of a model of secondary structure for the 188 nucleotides located in the 3-non coding region of STMV RNA based on its primary sequence
(5). The secondary structure is proposed by analogy to the folding determined for the 3'-end of TMV RNA (19). Shadowed nucleotides (large lettering) correspond
to single sequence changes. Compensatory base changes in helices are highlighted by circles. Diamonds show deletions and squares insertions. All other nucleotides
are strictly common to STMV and TMV RNAs. Major structural domains are classified by a letter code ranging from A to G. Non-canonical base-pairs in super
domain B-C and in domain F are indicated. The bold arrow emphasizes nucleotide A19 mimicking minus one nucleotide in canonical tRNAHiS. Notice that the
T-like loop and pseudoknot E are perfectly conserved in sequence and folding. In contrast to convention, numbering starts at the 3'-end of the molecule. Thus,
nucleotide 120 from this representation corresponds to nucleotide 940 in the genomic STMV RNA (5) and to nucleotide 6279 in the genomic TMV RNA (27).
Watson-Crick pairing between C92 or C93 and G59 is possible but has not been emphasized in the absence of experimental proves.
nt G40 to A58 and nt C94 to U107), belonging to the three-way
junction, show four sequence changes and one insertion witiin
the two single stranded regions (nt G44 to G52 and nt U98 to
U101) whereas 10 compensatory base changes in this domain
allow conservation of the two stacked helices (see Fig. 1).
Summarizing, the highest conservations between the
3'-terminal sequences of STMV and TMV RNAs concern the
helical and pseudoknotted regions; in contrast, the major
differences are located in the single-stranded connecting regions.
Here, sequence alterations are less important and do not disturb
the scaffolding of the molecule. Concerning individual domains,
we observe that domain A is similar to the amino acid accepting
branch of TMV RNA. It contains a continuous helix made of
11 base-pairs and a seven nucleotide long loop, including a
UUCG sequence mimicking the T4CG loop of canonical tRNAs
and a likely A31 -U35 Hogsteen pair. Sequence differences
within the helix are such that two compensatory base changes
restore its expected length. Both loops crossing the deep and
shallow groves of the pseudoknot present one additional
nucleotide and one sequence change as compared to TMV RNA.
Super domain B-C (nt C60 to G91), homologous to the anticodon
branch of TMV RNA, contains a 13 base-pair stack closed by
a GUG loop corresponding to an histidine anticodon triplet. The
helical part of the branch comprises two non-canonical base-pairs
(U64-U85 and C68-U81) and an internal bulge (nt A85 to G87)
which is two nucleotides shorter than that present in TMV RNA.
Taken together, we think that super domain B-C is less stable
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Figure 2. Charging kinetics of STMV (r) and TMV (1) RNAs aminoacylated
with yeast HisRS. Experiments were done under optimal enzyme concentration
and in the presence of equivalent molar amounts of RNA.
in STMV than in TMV RNA. Furthermore its junction to domain
A via pseudoknotted domain D appears less compact due to the
likely insertion of the unpaired nucleotides G59, C92, and C93.
The resulting increased flexibility may account for the functional
differences between STMV and TMV RNAs (see below).
Finally, the tRNA-like domain of STMV RNA is followed by
a stretch of pseudoknots (E, F, and G). Such an arrangement
was already proposed for STMV RNA, but with a slightly
different architecture for pseudoknot G (28). The new fold
proposed here mimics better the homologous structure present
in TMV RNA (20).
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Table 1. Kinetic parameters of histidylation of the STMV RNA relative to TMV RNA and to tRNAHiS transcript
RNA aminoacylation+ Km V,M Vm,lKm L L'
plateaus (arbitrary (arbitrary (relative to (relative to
(%) (nM) units) units) TMV-RNA) tRNAHis
STMV RNA 30 650 36 0.055 3.6 17
TMV RNA 98 90 18 0.2 1 4.7
yeast tRNAHIS 100 75 70 0.933 - I
+Aminoacylation levels were obtained with equivalent amounts of enzyme and correspond to optimal plateaus.
L and L' values correspond to losses of specificity and are expressed by either (Vma,jKm)TMV RNA/(Vmax/Km)STMV RNA or (Vmax/Km)tRNAHis /(Vmax/Km)STMV or
TMV RNA ratios.
Functional predictions
Two functional predictions can be proposed on the basis of the
3'-terminal secondary structure model of STMV RNA. The first
one concerns the regulatory mechanism of STMV genome
translation. Indeed, it has been recently demonstrated by extended
mutational analysis that the pseudoknotted domain in the helper
TMV RNA corresponding to the E-F-G region in STMV RNA
is directly involved in translational regulation during the TMV
life cycle (28). Strong effects occur after single sequence changes
in the two pseudoknots homologous to regions E and F in STMV
RNA. Interestingly, compensatory mutations restoring these
pseudoknots, only restore activity if they occur in the pseudoknot
homologous to F, thus indicating the strict sequence requirement
of domain E for translational regulation. Because of the strong
structural homology between STMV and TMV RNAs in this
region (with strict sequence and folding conservation in
pseudoknot E, see Fig. 1), it appears likely that both RNAs use
the same regulation mechanism for translation of their genomes,
especially since STMV is functionally dependent upon the
presence of its TMV helper.
Concerning a possible tRNA-like function of STMV RNA, our
results predict that this molecule should be charged by histidine.
As a prerequisite, it contains at its 3'-end the amino acid accepting
-CCAOH sequence universally conserved in amino acid
accepting RNAs and a GUG histidine anticodon located in super
domain B-C mimicking a tRNA anticodon branch. The presence
of this anticodon triplet within STMV RNA was already noticed
by Mans et al. (10), who thus perceived a tRNA-like potential
in this viral RNA. A possible tRNA-like fold at the 3'-end of
STMV RNA was also discussed by Solis and Garcia-Arenal when
comparing its sequence to that of another tobamovirus RNA,
namely tobacco mild green mosaic virus (TMGMV) (29). As
TMV RNA, which is histidine specific (18) and also canonical
histidine specific tRNAs, STMV RNA contains the major
histidine identity element (21, 22) properly located in its structure.
This element is a nucleotide at position -1 and is mimicked in
STMV RNA by residue A19 in the loop crossing the deep groove
of pseudoknot A.
Histidylation of STMV RNA
Figure 2 demonstrates explicidy the histidylation ability ofSTMV
RNA. Using yeast HisRS, up to 30% of the input viral RNA
molecules can be histidylated after 10 minutes of incubation with
the enzyme. This charging level is high but lower than that found
under the same experimental conditions for TMV RNA which
can be charged to nearly 100% (the slight decrease in the plateau
levels being reproducible).
A more quantitative estimate of the histidylation properties of
STMV RNA is given in Table 1. Here we compare the
Michaelis-Menten parameters V.,2 and Km of histidylation of
STMV RNA, TMV RNA and yeast tRNAHis transcript (we
recall that these three molecules are deprived of modified bases
and that the viral RNAs are full length molecules). First of all,
it can be seen that the histidylation efficiency of STMV RNA
is intrinsically high as compared to that of canonical tRNAHis,
the usual substrate of yeast HisRS; in terms of relative catalytic
efficiency it is only 17-fold less active than tRNAHis transcript
(thus TMV RNA charging is about 5-fold less efficient than
tRNAHis charging). The main outcome of this work, however,
is that the catalytic efficiency of the histidylation of STMV RNA
is quasi-equivalent to that ofTMV RNA (as expressed in relative
V,,,jaKmvalues). Indeed, STMV RNA charging is only 3.6-fold
less efficient than TMV RNA. Interestingly, however, the two
molecules behave differently with HisRS since the Km for
STMV RNA is significantly higher han that for TMV RNA (650
vs 90 nM) suggesting a lower affinity of the satellite RNA for
HisRS. This detrimental effect is partly overcome by a two-fold
higher V,. for charging of the STMV RNA. The reasons for
these mechanistic differences are not clearly understood, but it
may be proposed that a greater flexibility of STMV RNA
(because of the presence of non-canonical base-pairs and of
insertions, see above) could weaken affinity with HisRS (Km
effect) but in contrast also facilitate the functional adaptation of
the RNA with the synthetase (V,,. effect).
The kinetic differences between STMV and TMV RNA
charging could also be due to the presence of different levels
of unchargeable molecules in the two RNA preparations. The
fact that the aminoacylation plateau of STMV is lower than that
of TMV RNA (see Fig. 2) agrees with this view. Inactive
molecules could arise from the greater structural plasticity of
STMV RNA which would favour alternate foldings of the
molecule. An attractive possibility would be a circularization of
the RNA by pairing of its 5'- and 3'-termini. Such circularization
has already been discussed for plant viral RNAs terminating with
a tRNA-like domain (30) and its occurrence is also possible for
STMV RNA (7).
General conclusions and biological perspectives
RNA viruses are often accompanied by satellite viruses as found
in many instances with plant viruses. Satellite and helper viruses
are functionally related since they infect the same host and since
replication of the satellite is dependent upon that of its helper
(31-33). However the mechanisms ofthis dependence are mostly
not well defined at the molecular level. Up to now it was not
clear whether this functional relationship occurs also at the
structural level, especially since no clear sequence homologies
between RNAs from helper and satellite viruses exist (32).
Exceptions concern the virulent satellite RNA of turnip crinkle
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virus (34) and to a lesser extent the satellite RNA of cucumber
mosaic virus (35), in which some similarity with the genomic
helper RNAs appears at the 3'-termini. We report here a strong
structural homology at the level of the secondary and tertiary
structure between the 3'-termini of the RNAs from STMV and
TMV.
TMV RNA presents an aminoacylatable tRNA-like domain at
its 3'-end as do several other plant viral genomic RNAs [reviewed
in (9-11)]. These domains are not involved in protein synthesis
(9, 36) and no general rule has so far appeared for their
occurrence and for the necessity of their aminoacylation. As a
general role of these structures, a tempting suggestion is that of
a telomer function which would protect the viral RNAs from
exoribonuclease cleavages (37-38). Other hypotheses have been
proposed (30), but only three have been experimentally
documented. In TMV RNA, the tRNA-like domain increases both
translational efficiency and RNA stability (39). In BMV RNA
the tRNA-like domain is the initiation site for minus strand
synthesis, although aminoacylation seems not to be required (40,
41). Finally and in contrast, replication is dependent upon
aminoacylation of the tRNA-like domain in TYMV RNA (42).
We note that another virus infecting tobacco, tobacco necrosis
virus (TNV) can also be accompanied by a satellite virus (STNV).
Although a mimicry with tRNAMet was suggested at the
3'-terminus of STNV RNA (43), it is likely that no tRNA-like
folding exists at that level (44). Moreover, no apparent sequence
similarity exists between this RNA and its helper RNA (45). This
situation contrasts with what observed in TMV and STMV
RNAs. It follows that different satellite viruses, even infecting
the same host, may require different mechanisms for their
expression.
Concluding, we describe for the first time the presence of an
aminoacylatable tRNA-like structure at the 3'-end of the RNA
from a satellite virus. This tRNA-like structure is the only domain
witiin STMV RNA bearing strong sequence similarity with the
helper TMV RNA. This similarity is even higher at the level
of the secondary and tertiary structures. Since replication of
STMV RNA is strictly dependent upon the presence of its helper,
and since both RNAs possess a similar tRNA-like domain at their
3'-termini, it appears likely that this domain represents a
recognition signal for the common viral replicase. Thus STMV
RNA would use the same replicative mechanism as the RNA from
the helper TMV. Following this view, and as shown for TMV
RNA (39), we propose that the tRNA-like structure in STMV
is essential for translational efficiency and stability of its RNA.
This prediction can be verified with engineered STMV mutants
lacking their tRNA-like termini which should become inefficient
for replication and/or translation.
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